KIR2DL1 and KIR2DL2 expression did not demonstrate differences between GBM and non-tumor samples in TCGA database (p = 0.08 and 0.69, respectively), while KIR2DL3 expression demonstrated differences (p < 0.01). This evidence concerns the gene KIR2DL3 and glioblastoma.